Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Mar 18;184(6):1545-1560.
doi: 10.1016/j.cell.2021.02.007. Epub 2021 Mar 9.

Adapting the proteostasis capacity to sustain brain healthspan

Affiliations
Free article
Review

Adapting the proteostasis capacity to sustain brain healthspan

Claudio Hetz. Cell. .
Free article

Abstract

Sustaining neuronal proteostasis during the course of our life is a central aspect required for brain function. The dynamic nature of synaptic composition and abundance is a requisite to drive cognitive and motor processes involving a tight control of many aspects of protein biosynthesis and degradation. Through the concerted action of specialized stress sensors, the proteostasis network monitors and limits the accumulation of damaged, misfolded, or aggregated proteins. These stress pathways signal to the cytosol and nucleus to reprogram gene expression, enabling adaptive programs to recover cell function. During aging, the activity of the proteostasis network declines, which may increase the risk of accumulating abnormal protein aggregates, a hallmark of most neurodegenerative diseases. Here, I discuss emerging concepts illustrating the functional significance of adaptive signaling pathways to normal brain physiology and their contribution to age-related disorders. Pharmacological and gene therapy strategies to intervene and boost proteostasis are expected to extend brain healthspan and ameliorate disease states.

PubMed Disclaimer

Conflict of interest statement

Declaration of interests C.H. is co-inventor on several patents for gene therapy targeting proteostasis, some of which are licensed to Handl Therapeutics. C.H. has a service contract with Handl Therapeutics to further develop these technologies.

Publication types

LinkOut - more resources